{"id":31869,"date":"2023-05-10T08:00:00","date_gmt":"2023-05-10T06:00:00","guid":{"rendered":"https:\/\/www.transgene.com\/?p=31869"},"modified":"2026-07-09T14:55:20","modified_gmt":"2026-07-09T12:55:20","slug":"transgene-premier-patient-traite-dans-lessai-de-phase-i-evaluant-tg6050-un-virus-oncolytique-innovant-arme-avec-de-lil-12-dans-le-cancer-du-poumon-non-a-petites-cellules","status":"publish","type":"post","link":"https:\/\/www.transgene.com\/fr\/transgene-premier-patient-traite-dans-lessai-de-phase-i-evaluant-tg6050-un-virus-oncolytique-innovant-arme-avec-de-lil-12-dans-le-cancer-du-poumon-non-a-petites-cellules\/","title":{"rendered":"Transgene &#8211; Premier patient trait\u00e9 dans l&rsquo;essai de Phase I \u00e9valuant TG6050, un virus oncolytique innovant arm\u00e9 avec de l&rsquo;IL-12, dans le cancer du poumon non \u00e0 petites cellules"},"content":{"rendered":"\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n\n\n\n<p class=\"eplus-DVrMbh\"><a href=\"https:\/\/www.transgene.com\/wp-content\/uploads\/20230510_Transgene_TG6050_Delivir_trial_FPI_FR.pdf\">Premier patient trait\u00e9 dans l&rsquo;essai de Phase I \u00e9valuant TG6050<\/a><\/p>\n\n\n","protected":false},"excerpt":{"rendered":"<p>&nbsp; &nbsp; Premier patient trait\u00e9 dans l&rsquo;essai de Phase I \u00e9valuant TG6050<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","_uag_custom_page_level_css":"","footnotes":""},"categories":[164,11,128,56,169],"tags":[],"class_list":["post-31869","post","type-post","status-publish","format-standard","hentry","category-164","category-press-release-fr","category-dates","category-invirio-fr","category-tg6050_fr","entry"],"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"post-thumbnail":false},"uagb_author_info":{"display_name":"nh","author_link":"https:\/\/www.transgene.com\/fr\/author\/nh\/"},"uagb_comment_info":0,"uagb_excerpt":"&nbsp; &nbsp; Premier patient trait\u00e9 dans l&rsquo;essai de Phase I \u00e9valuant TG6050","_links":{"self":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/31869","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/comments?post=31869"}],"version-history":[{"count":1,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/31869\/revisions"}],"predecessor-version":[{"id":41509,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/31869\/revisions\/41509"}],"wp:attachment":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/media?parent=31869"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/categories?post=31869"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/tags?post=31869"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}